Diagnostic moléculaire des hémopathies lymphoïdes matures Molecular diagnosis of mature lymphoproliferative disorders

The understanding of the molecular mechanisms associated to lymphoid neoplasia has significantly improved in recent years due to technological advances. Molecular markers have been identified, allowing initial diagnosis. Genomic rearrangements can help to affirm clonality or indicate the disease entity. Some markers are also researched for their prognostic value. Finally, some rearrangements can be used for residual disease assessment during clinical course. To cite this journal: Oncologie 13 (2011).